Workflow
化学原料和化学制品制造业
icon
Search documents
南开和成完成IPO辅导备案,董事长马玉新控股37%
Sou Hu Cai Jing· 2025-12-24 00:44
瑞财经 严明会 12月19日,天津南开和成科技股份有限公司(以下简称:南开和成)在天津证监局完成IPO辅导备案,辅导机构广 发证券。 南开和成成立于2001年,注册资本3143.5万元,是一家以从事化学原料和化学制品制造业为主的企业。 南开和成控股股东为董事长兼总经理马玉新,合计控制公司37%股权。招银国际资本、蓝驰创投、创世因特等参与投资。 南开和成对外投资有4家公司,包括和成沧州医药科技有限公司、天津时金新材料有限公司、和成(苏州)科技有限公司等。 ...
董事长专访 | 大洋生物陈阳贵:扎扎实实谋发展,矢志打造长青基业
Sou Hu Cai Jing· 2025-12-24 00:11
"大洋生物的文化是立足现有优势产品,沉下心来把它做精、做深、做细、做优,做出规模效应。"大洋 生物董事长陈阳贵说,公司不搞花架子,而是扎扎实实地把钾盐主业做强,同时让兽药和含氟精细化学 品这两翼协同发展。 一脉清泉,自群山奔涌而出,入兰江,汇钱塘,浩浩荡荡奔向东海。兰江从山涧走向大海,大洋生物也 从兰江畔出发,用约五十年时间完成了从社办企业到全球细分市场龙头的跨越。 在陈阳贵看来,这主要得益于几个关键布局,放在首要位置的就是深化公司"一体两翼"格局。一方面, 公司不断强化技术创新,提升产品竞争力,助推规模化发展,让钾盐这个"主体"在全球的地位更牢固; 另一方面,让"两翼"(含氟精细化学品和兽药)真正"飞"起来,成为重要的增长点。 为夯实主业,大洋生物把"专精"刻入发展基因,坚信"技术就是硬道理",选择"死磕"技术。"最让团队 自豪的就是自主研发的'离子交换闭路循环系统及高效蒸发生产碳酸钾工艺',既显著降低了生产能耗, 又实现了含氨氮废水的资源化利用,走出一条绿色高效的可持续发展之路。"陈阳贵说。 除了技术过硬之外,产品定位"高精尖"是大洋生物多年发展的又一经验。"碳酸钾属于轻质碳酸钾,具 有堆积密度小、比表面 ...
ST沈化索赔递交立案,曾被监管处罚维权还可加入
Xin Lang Cai Jing· 2025-12-23 23:23
一、部分案件获法院受理 受损股民可至新浪股民维权平台登记该公司维权:http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们! 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们! 近日,上海沪紫律师事务所刘鹏律师团队代理的案件获法院受理并选定某投资者案件作为示范性案例。 (刘鹏律师专栏) 回溯此案,2025年11月28日,沈阳化工收到一纸来自中国证券监督管理委员会辽宁监管局的《行政处罚 决定书》,为其长达四年的系统性财务造假行为画上了句点。 现符合于2019年3月21日-2023年4月28日(含当日)期间买入,并在2023年4月29日之后卖出或仍持 有而亏损的即可参与维权。对此,辽宁证监局拟决定对沈阳化工给予警告,并处以700万元罚款,相关 责任人纷纷被罚。(沈阳化工维权入口) 这不仅是一场对公司治理和内部控制的拷问,更对资本市场诚信和投资者权益造成了严重损害。目前符 合要求皆可加入。 二、多年财报存在造假 据监管调查,公司的全资子公司沈阳石 ...
大洋生物陈阳贵:扎扎实实谋发展,矢志打造长青基业
Core Viewpoint - The article highlights the evolution of Dayang Biological from a collective enterprise to a global leader in niche markets over approximately fifty years, emphasizing its commitment to refining its core potassium salt business while developing its two wings: veterinary medicine and fluorine fine chemicals [2][3]. Group 1: Company Development and Strategy - Dayang Biological has focused on deepening its core business and enhancing product quality, which has led to significant achievements in the potassium carbonate market [3][4]. - The company has established a robust supply chain, allowing it to reduce reliance on upstream raw materials and optimize its industrial chain [3][4]. - The firm aims to solidify its position in the global potassium carbonate market, targeting a market share of nearly 50% by 2024 [4]. Group 2: Financial Performance - In the first three quarters of 2025, Dayang Biological reported a revenue of 747 million yuan, representing a year-on-year growth of 11.24%, while net profit attributable to shareholders reached 80.04 million yuan, up 56.12% [4]. Group 3: Technological Innovation and Sustainability - The company has developed a proprietary ion exchange closed-loop system and efficient evaporation process for potassium carbonate production, significantly reducing energy consumption and promoting wastewater resource utilization [4][6]. - Dayang Biological's products are characterized by high quality and precision, making them suitable for high-end applications in food, pharmaceuticals, and pesticides [4][6]. Group 4: Market Expansion and Global Reach - Dayang Biological has established long-term partnerships with over 20 domestic and international listed companies, expanding its market presence to more than 50 countries and regions [4][6]. - The company is actively exploring new markets, including semiconductor materials, and is collaborating with institutions to enhance product applications in feed additives [8][9]. Group 5: Organizational Structure and Culture - The company emphasizes a scientific personnel management system and incentive mechanisms, which are crucial for its stable development [7][8]. - Dayang Biological has a strong focus on talent cultivation and technological innovation, being recognized as a national high-tech enterprise and a "little giant" in specialized and innovative sectors [9].
巴斯夫,50万吨/年的大项目投产
DT新材料· 2025-12-23 16:05
Core Viewpoint - The article highlights the successful operation of BASF's polyethylene plant in Guangdong, marking a significant milestone in the company's investment and production capabilities in China [1][2]. Group 1: BASF's Investment and Production - BASF's integrated base in Zhanjiang represents the company's largest single investment project to date, with a total investment of approximately €10 billion [2]. - The facility will become BASF's third-largest production base globally, following Ludwigshafen in Germany and Antwerp in Belgium [2]. - The core production units include a steam cracker with an annual capacity of 1 million tons of ethylene and various downstream facilities serving multiple industries such as automotive, construction, and pharmaceuticals [2][3]. Group 2: Technological Innovations - The project incorporates a lightweight hydrocarbon recovery system that significantly reduces nitrogen gas consumption and enhances hydrocarbon recovery rates [2]. - It features an energy recovery unit to maximize waste heat utilization and addresses emissions monitoring challenges, achieving pollution control at an internationally leading level [2]. - The facility utilizes seawater for cooling, resulting in minimal freshwater consumption, aligning with sustainable development principles [2]. Group 3: Future Industry Exhibition - The 2026 Future Industry New Materials Expo will focus on common needs in future industries such as robotics, automotive, drones, and AI [1]. - The exhibition will include six major areas, emphasizing lightweight, high-strength, and sustainable materials [1][5]. - Over 800 enterprises and research institutions are expected to participate, showcasing innovations in various sectors including quantum technology, 6G, and new energy equipment [6][8].
双乐股份:第三届董事会第十四次会议决议公告
Zheng Quan Ri Bao· 2025-12-23 14:26
(文章来源:证券日报) 证券日报网讯 12月23日,双乐股份发布公告称,公司第三届董事会第十四次会议审议通过《关于进一 步明确公司向不特定对象发行可转换公司债券方案的议案》等多项议案。 ...
闰土股份:截至2025年12月19日股东人数为33908户
Zheng Quan Ri Bao Wang· 2025-12-23 13:47
证券日报网讯12月23日,闰土股份(002440)在互动平台回答投资者提问时表示,截至2025年12月19 日,公司的股东人数为33908户。 ...
凯盛新材:公司PEKK产品的良品率不断提升,市场开拓正在按计划进行
Zheng Quan Ri Bao Wang· 2025-12-23 13:45
Core Viewpoint - The company has reported an increase in the yield rate of its PEKK products and is progressing with market expansion as planned [1] Group 1: Product Performance - The yield rate of PEKK products has been continuously improving throughout the year [1] - The company is actively expanding its market presence for PEKK products [1] Group 2: Cost Advantage - PEKK has a cost advantage over PEEK due to its use of lower-cost raw materials such as isophthaloyl chloride and diphenyl ether [1] - The production process of PEKK involves electrophilic substitution to prepare diols, which is less costly compared to the high-temperature nucleophilic method used for PEEK [1]
建龙微纳(688357.SH)子公司拟2亿元收购汉兴能源40%股权
智通财经网· 2025-12-23 12:01
Core Viewpoint - Jianlong Micro-Nano (688357.SH) announced a strategic acquisition of 40% equity in Shanghai Hanxing Energy Technology Co., Ltd. for a transaction amount of 200 million yuan, marking a significant business layout in line with its development strategy [1] Group 1 - The acquisition is aimed at enhancing the company's operational capabilities and achieving synergy with the target company [1] - This transaction represents a strategic leap for the company from being a material manufacturer to a comprehensive technology service provider [1]
建龙微纳:全资子公司拟收购上海汉兴能源科技股份有限公司40%股权
Mei Ri Jing Ji Xin Wen· 2025-12-23 11:26
(记者 王晓波) 截至发稿,建龙微纳市值为32亿元。 每经头条(nbdtoutiao)——地产"优等生"受困20亿元到期债务,首次债务展期仍在博弈,明年还有超 百亿元公开债到期 每经AI快讯,建龙微纳(SH 688357,收盘价:32元)12月23日晚间发布公告称,公司根据自身发展战 略和经营发展需要,公司全资子公司上海建龙微纳新材料科技有限公司(简称"上海建龙")拟收购上海 汉兴能源科技股份有限公司(简称"汉兴能源"、"标的公司"或"目标公司")40.00%股权,交易金额为人 民币贰亿元整(2亿元)。本次交易完成后,上海建龙对汉兴能源的持股比例为40%,汉兴能源将成为 公司全资子公司上海建龙的参股公司。 2024年1至12月份,建龙微纳的营业收入构成为:化学原料和化学制品制造业占比100.0%。 ...